- Home
- ALEC vs ORGO Comparison
ALEC vs ORGO Comparison
Compare ALEC & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- ORGO
- Stock Information
- Founded
- ALEC 2013
- ORGO 1985
- Country
- ALEC United States
- ORGO United States
- Employees
- ALEC N/A
- ORGO N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- ALEC Health Care
- ORGO Health Care
- Exchange
- ALEC Nasdaq
- ORGO Nasdaq
- Market Cap
- ALEC 454.5M
- ORGO 408.3M
- IPO Year
- ALEC 2019
- ORGO N/A
- Fundamental
- Price
- ALEC $3.94
- ORGO $4.05
- Analyst Decision
- ALEC Strong Buy
- ORGO Strong Buy
- Analyst Count
- ALEC 5
- ORGO 3
- Target Price
- ALEC $20.67
- ORGO $5.33
- AVG Volume (30 Days)
- ALEC 774.1K
- ORGO 751.5K
- Earning Date
- ALEC 11-06-2024
- ORGO 11-12-2024
- Dividend Yield
- ALEC N/A
- ORGO N/A
- EPS Growth
- ALEC N/A
- ORGO N/A
- EPS
- ALEC N/A
- ORGO N/A
- Revenue
- ALEC $61,508,000.00
- ORGO $455,038,000.00
- Revenue This Year
- ALEC N/A
- ORGO $7.42
- Revenue Next Year
- ALEC $118.87
- ORGO $0.08
- P/E Ratio
- ALEC N/A
- ORGO N/A
- Revenue Growth
- ALEC N/A
- ORGO 1.34
- 52 Week Low
- ALEC $3.49
- ORGO $2.17
- 52 Week High
- ALEC $8.90
- ORGO $4.71
- Technical
- Relative Strength Index (RSI)
- ALEC 38.47
- ORGO 64.80
- Support Level
- ALEC $3.49
- ORGO $3.76
- Resistance Level
- ALEC $6.14
- ORGO $4.16
- Average True Range (ATR)
- ALEC 0.48
- ORGO 0.29
- MACD
- ALEC -0.17
- ORGO 0.05
- Stochastic Oscillator
- ALEC 16.98
- ORGO 67.70
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.